FindTrial
Sign In

The assessment of the endothelial function using aldosterone receptor blockade in patients with hypertension

The assessment of the endothelial function using aldosterone receptor blockade in patients with hypertension - EPLENDO

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001199
Enrollment
50
Registered
2009-01-01
Start date
2008-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

essential hypertension

Interventions

Eplerenone Ca blockers

Sponsors

Hiroshima Endothelial Function Study Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: essential hypertension

Exclusion criteria

Exclusion criteria: secondary hypertension

Design outcomes

Primary

MeasureTime frame
blood pressure, heart rate, FMD, EPC—

Countries

Japan

Contacts

Public ContactTakaki Hata

Hiroshima University Department of Cardiovascular Medicine

superhatachan@gmail.com0822575555

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026